Asia to Be the Fastest-Growing Market for Genomic DNA Isolation and Purification

The major factors driving the growth of the market include increasing public-private funding for life science research, technological advancements, and increasing automated systems in the nucleic acid isolation and purification market.

The global Nucleic Acid Isolation and Purification Market is expected to reach USD 6.85 billion by 2027 from USD 2.77 billion in 2018, at a CAGR of 9.6%.

On the basis of product, the nucleic acid isolation and purification market is segmented into instruments, kits, and reagents. In 2018, the kits segment is expected to account for the largest share of the market. The large share of this segment can be attributed to their low cost and ease of handling in applications such as gene sequencing, molecular diagnostics, and gene cloning.

Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=229978287

On the basis of application, the nucleic acid isolation and purification market is segmented into diagnostics; drug discovery and development; personalized medicine; agriculture and animal research; and other applications (such as forensics and biofuel research). In 2018, the diagnostics segment is expected to account for the largest share of the market and it is also expected to register the highest CAGR during the forecast period. The large share of the diagnostics segment can be attributed to the increasing awareness of genomic diagnostics among the patient population and increasing efficiency of genomics sequencing in the diagnosis of diseases.

On the basis of method, the nucleic acid isolation and purification market is segmented into column-based isolation and purification, reagent-based isolation and purification, magnetic bead-based isolation and purification, and other methods. In 2018, the column-based isolation and purification segment is expected to account for the largest share of the global nucleic acid isolation and purification market. This method is widely adopted because it is cost-effective, simpler, and faster than organic extraction, and can also be automated.

Regional Analysis:-
By region, the nucleic acid isolation and purification market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). In 2018, North America is expected to account for the largest share of the market. Significant R&D spending in biotechnology and pharmaceutical companies, technological advancements, and government support are the key factors driving the growth of the nucleic acid isolation and purification market in North America.

Read more: - https://www.marketsandmarkets.com/PressReleases/nucleic-acid-isolation-purification.asp

Top Key Players:-

The nucleic acid isolation and purification market is highly consolidated with few major companies holding a majority of the market share. In 2018, QIAGEN (Netherlands), Thermo Fisher Scientific (US), and Roche (Switzerland) are expected to dominate the nucleic acid isolation and purification market. Other prominent players in this market include Merck KGaA (Germany), Agilent Technologies (US), Illumina (US), Takara Bio (Japan), Promega Corporation (US), GE Company (US), Danaher Corporation (US), New England Biolabs (US), and Bio-Rad Laboratories (US).

Increasing Demand for Infusion Pump in Developing Economies

The increasing prevalence of chronic diseases along with the rapid growth in the geriatric population, growing use of ambulatory infusion pumps in home care settings, and growing number of surgical procedures are some of the key factors driving the growth of the infusion pumps market.

The global Infusion Pump Market is expected to grow to reach USD 16.8 billion by 2027 from USD 12.6 billion in 2019, at a CAGR of 6.0% during the forecast period.

On the basis of products, the accessories/consumables segment accounted for the largest share of the infusion pumps market in 2018. This can be attributed to the recurrent use of accessories/consumables during infusion therapy for the management of chronic diseases. The accessories/consumables segment is further segmented into dedicated accessories/consumables and non-dedicated accessories/consumables. Dedicated accessories/consumables for infusion pumps accounted for the largest share of the infusion pump accessories/consumables market in 2018.

PDF Brochure:-  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=90374506

The infusion pump devices segment includes volumetric infusion pumps, syringe infusion pumps, insulin infusion pumps, ambulatory infusion pumps, enteral infusion pumps, patient-controlled analgesia infusion pumps, and implantable infusion pumps. The insulin infusion pumps is expected to grow at the highest CAGR, owing to its wide applications for delivering large volumes of fluids to patients at predetermined medium-to-high flow rates. These devices are useful for almost all areas of healthcare and are widely used for IVs.

Based on applications, the infusion pumps market is segmented into chemotherapy/oncology, diabetes, gastroenterology, analgesia/pain management, pediatrics/neonatology, hematology, and other applications. Other applications include infectious diseases, autoimmune diseases, and diseases of the heart, kidney, lung, and liver. The chemotherapy/oncology segment accounted for the largest share of the global infusion pumps market in 2018.

Based on end users, the market is segmented into hospitals, health care settings, ambulatory care settings, and academic and research institutes. In 2018, the hospitals accounted for the largest share.

Read more:- https://www.marketsandmarkets.com/PressReleases/infusion-pumps-accessories.asp

Regional Analysis:- 
North America accounted for the largest share of the infusion pumps market in 2018, followed by Europe. This is mainly due to the increasing prevalence of chronic diseases, growing demand for advanced medical treatment, and growing healthcare market in the region. The growing demand for premium-priced infusion pump systems, to improve the quality of care for patients, is expected to play a key role in the growth of the infusion pumps market in North America in the coming years.

Top Key players:-
The prominent players in the infusion pumps market are Becton, Dickinson and Company (US), Baxter (US), ICU Medical (US), B. Braun (Germany), Fresenius Kabi (Germany), Medtronic (Ireland), Smiths Medical (US), Terumo Corporation (Japan), Moog (US), Roche Diagnostics (Switzerland), Halyard Health (US), Mindray Medical (China), Micrel Medical (Greece), and Insulet Corporation (US).

Increasing Use of Stem Cell Therapy is Paving New Growth Avenues for Players in the Nerve Repair Market

Nerve repair and regeneration products are used by medical professionals to restore normal function to damaged nerves. Nerve injuries are common in the upper (hand and arm) and lower (leg) extremities. Nerve damage can be caused either due to blunt trauma (such as an impact from a fall or from traction injuries from motor vehicle accidents) or sharp trauma (such as from a direct cut from a knife). Surgical nerve repair involves the exploration of the injured nerve and removal of injured tissue from the nerve endings.

The Nerve Repair and Regeneration Market is expected to reach USD 10.59 Billion by 2022 from USD 5.79 Billion in 2017, at a CAGR of 12.9%. Increasing number of neurological disorders, rising geriatric population, and technological advancements are the major factors that are driving the growth of this market.

Major Market Developments:-

• In June 2015, Boston Scientific launched precision novi spinal cord stimulator system in Europe and received CE Mark approval for it
• In January 2016, Polyganics (the Netherlands) signed an agreement with MicroAire Surgical Instruments (US) to distribute its peripheral nerve repair products in the US and Canada
• In January 2017, Abbott Laboratories acquired St. Jude Medical to strengthen its position in the neuromodulation market
•  In September 2017, Medtronic (Ireland) received FDA approval Intellis platform spinal cord stimulator (SCS)
• In May 2015, Axogen (US) received FDA approval for Avance nerve graft

Download PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=883  

Market Drivers:-

• High incidence of nerve injuries and growing prevalence of neurological disorder
• Increase in geriatric population and subsequent growth in the prevalence of neurological disorder
• Technological advancement

Regional Analysis:-

By region, the nerve repair and regeneration market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). The market is dominated by North America, followed by Europe; however, the Asian region is expected to witness the highest growth during the forecast period. The presence of emerging economies like China and India; large population; growth in the number of hospitals, and increasing neurological disorders in the region are some of the key factors driving the high growth of this regional segment.

Read more: - https://www.marketsandmarkets.com/PressReleases/nerve-repair-regeneration.asp

Top key Players:-
Some of the major players operating in the nerve repair and regeneration market are AxoGen (US), Baxter (US), Boston Scientific (US), LivaNova (UK), Integra LifeSciences (US), Medtronic (US), Abbott Laboratories (US), Stryker (US), Nevro (US), Polyganics (Netherlands), and Nuvectra (US).

Growth in the Biopharmaceutical Industry is Propelling the Growth of the Pharmaceutical Membrane Filtration Market

Factors such as adoption of the nanofiltration technology, growth in the biopharmaceutical industry, and rapid development in generics production are driving the growth of this market. On the other hand, stern regulatory requirements and high price constraints are restraining the growth of this market.

The global Pharmaceutical Membrane Filtration Market is expected to reach USD 6.20 Billion by 2021 from USD 3.55 Billion in 2016, at a CAGR of 11.8% from 2016 to 2021. Factors such as growth in the biopharmaceutical industry and rapid growth in generic drug production are driving the growth of this market.

Download Free PDF Brochure: - http://www.marketsandmarkets.com/pdfdownload.asp?id=255408031

In this report, the global pharmaceutical membrane filtration market has been segmented based on product, technique, application, and region.
On the basis of product, the market has been segmented into MCE membrane filters, coated cellulose acetate membrane filters, nylon membrane filters, PTFE membrane filters, PVDF membrane filters, and other membrane filters.

Based on technique, the pharmaceutical membrane filtration market has been segmented into microfiltration, ultrafiltration, crossfiltration, nanofiltration, reverse osmosis, and ion exchange. The microfiltration segment is projected to witness the highest CAGR during the forecast period.

Based on application, the global pharmaceutical membrane filtration market is segmented into final product processing, raw material filtration, cell separation, water purification, and air purification. The final product processing segment is further divided into active pharmaceutical ingredient (API) filtration, sterile filtration, protein purification, vaccines & antibody processing, formulation & filling solutions, and viral clearance.

Regional Analysis:-
Based on region, the global pharmaceutical membrane filtration market is segmented into North America, Asia, Europe, and the Rest of the World (RoW). North America is expected to account for the largest share of the market in 2016. Growth in this regional segment is driven by factors such as increase in generic drug production and increasing incidence of airborne diseases.

Read More: - https://www.marketsandmarkets.com/PressReleases/pharmaceutical-membrane-filtration.asp

Top Key Players:-
Key players in the pharmaceutical membrane filtration market include Merck KGaA (Germany), General Healthcare Company (U.K.), Pall Corporation (U.S.), Sartorius Stedim Biotech Group (France), Alfa Laval (Sweden), Graver Technologies, LLC (U.S.), Koch Membrane Systems Inc. (U.S.), GEA Group (Germany), and Novasep (U.S.).